2022年3月14日，欧盟食品安全局（EFSA）发布关于梨果、杏和桃中多效唑（paclobutrazol）的最大残留限量审查后确认数据的评估。
根据提交的新数据，对多效唑和三唑衍生物代谢物的风险评估进行了更新，未显示任何消费者摄入问题。部分原文报道如下：
The applicant Proplan Plant Protection Company submitted a request to the competent national authority in Austria (originally the United Kingdom) to evaluate the confirmatory data that were identified for paclobutrazol in the framework of the MRL review under Article 12 of Regulation (EC) No 396/2005 as not available. To address the data gaps, two new metabolism studies performed on apples were submitted. In addition, two studies on the magnitude of residues in apples and pears providing data for triazole derivative metabolites were also submitted. The data gaps were considered satisfactorily addressed. The new information provided did not require a revision of the existing MRLs for pome fruits, apricots and peaches. An update of the risk assessment was performed for paclobutrazol and for the triazole derivative metabolites in light of the new data submitted and did not indicate any consumer intake concerns.
